187 related articles for article (PubMed ID: 26408330)
1. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.
Boys JA; Worrell SG; Chandrasoma P; Vallone JG; Maru DM; Zhang L; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Molena D; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):6-12; discussion 12. PubMed ID: 26408330
[TBL] [Abstract][Full Text] [Related]
2. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
Sgourakis G; Gockel I; Lang H
World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
[TBL] [Abstract][Full Text] [Related]
5. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
7. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH
J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
9. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.
Dunbar KB; Spechler SJ
Am J Gastroenterol; 2012 Jun; 107(6):850-62; quiz 863. PubMed ID: 22488081
[TBL] [Abstract][Full Text] [Related]
10. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.
van de Ven SEM; Suzuki L; Gotink AW; Ten Kate FJC; Nieboer D; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Curvers W; van Lijnschoten IG; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
United European Gastroenterol J; 2021 Nov; 9(9):1066-1073. PubMed ID: 34609076
[TBL] [Abstract][Full Text] [Related]
12. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases.
Molena D; Schlottmann F; Boys JA; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Mungo B; Watson TJ; DeMeester SR
J Gastrointest Surg; 2017 Jan; 21(1):62-67. PubMed ID: 27561633
[TBL] [Abstract][Full Text] [Related]
13. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
14. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
15. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma.
Schwameis K; Green KM; Worrell SG; Samaan J; Cooper S; Tatishchev S; Oh DS; Hagen JA; DeMeester SR
Ann Surg Oncol; 2017 Dec; 24(13):3921-3925. PubMed ID: 28975518
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma.
Maish MS; DeMeester SR
Ann Thorac Surg; 2004 Nov; 78(5):1777-82. PubMed ID: 15511474
[TBL] [Abstract][Full Text] [Related]
18. Lymph-node metastasis in surgical resection of intramucosal esophageal adenocarcinoma.
Oda I; Yamada M; Yoshinaga S; Tachimori Y; Kushima R
Dig Endosc; 2013 May; 25 Suppl 2():177-80. PubMed ID: 23617673
[TBL] [Abstract][Full Text] [Related]
19. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
Weksler B; Kennedy KF; Sullivan JL
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1787-1793. PubMed ID: 28867381
[TBL] [Abstract][Full Text] [Related]
20. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
